Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, November 23, 2014
Technology Networks
 
Register | Sign in
Home Page>News

  News Archive

Charge-Tagged Proline-Based Organocatalyst for Mechanistic Studies Using ESI-MS
Friday, November 14, 2014
In a comparative continous flow ESI-MS study, researchers use a new charged catalyst and neutral L-proline to investigate the proline-catalyzed inverse crossed aldol reaction of aldehydes with diethyl ketomalonate.

Beckman, U of Birmingham Form Technology Collaboration
Tuesday, November 04, 2014
The partnership is aimed at advancing automation techniques for regulatory science research.

Bruker Sells GC Business
Tuesday, November 04, 2014
Bruker completed the divestiture of its GC and GC single-quadrupole (GC-SQ) mass spectrometry products to Techcomp Europe Ltd on October 31st.

Mass Spec Sample Prep Cut From Days to Minutes
Monday, November 03, 2014
The method, developed by Livermore scientists, accommodates liquid samples and bypasses the graphitization process, enabling sample preparation and analysis in minutes.

Molecular Profiles, Xceleron Drug Development Partnership
Saturday, November 01, 2014
Companies announce a collaboration to assist drug developers with improved efficiency during clinical development.

AB SCIEX Wins New Product Innovation Award in Asia Pacific
Thursday, October 30, 2014
The award recognizes the company’s continued innovation in the mass spectrometry industry and a number of new products introduced into the market in recent years.

Waters Centers of Innovation Program Honors CSU Laboratory
Wednesday, October 29, 2014
Proteomics and metabolomics facility recognized for innovation in biological mass spectrometry.

LLNL, UC Davis Partner to Personalize Cancer Medications
Wednesday, October 29, 2014
With a $7.8 million, five-year grant from the NIH researchers are utilizing accelerator mass spectrometry for cancer research.

Novel Solutions to Fight the Obesity Gene
Wednesday, October 29, 2014
Potent inhibitors a potential new class of anti-obesity drugs that target one of the most common genetic causes of obesity.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 1260
SELECTBIO
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv